PMID- 23082852 OWN - NLM STAT- MEDLINE DCOM- 20130930 LR - 20130121 IS - 1474-9726 (Electronic) IS - 1474-9718 (Linking) VI - 12 IP - 1 DP - 2013 Feb TI - NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model. PG - 11-23 LID - 10.1111/acel.12018 [doi] AB - While the spatiotemporal development of Tau pathology has been correlated with occurrence of cognitive deficits in Alzheimer's patients, mechanisms underlying these deficits remain unclear. Both brain-derived neurotrophic factor (BDNF) and its tyrosine kinase receptor TrkB play a critical role in hippocampus-dependent synaptic plasticity and memory. When applied on hippocampal slices, BDNF is able to enhance AMPA receptor-dependent hippocampal basal synaptic transmission through a mechanism involving TrkB and N-methyl-d-Aspartate receptors (NMDAR). Using THY-Tau22 transgenic mice, we demonstrated that hippocampal Tau pathology is associated with loss of synaptic enhancement normally induced by exogenous BDNF. This defective response was concomitant to significant memory impairments. We show here that loss of BDNF response was due to impaired NMDAR function. Indeed, we observed a significant reduction of NMDA-induced field excitatory postsynaptic potential depression in the hippocampus of Tau mice together with a reduced phosphorylation of NR2B at the Y1472, known to be critical for NMDAR function. Interestingly, we found that both NR2B and Src, one of the NR2B main kinases, interact with Tau and are mislocalized to the insoluble protein fraction rich in pathological Tau species. Defective response to BDNF was thus likely related to abnormal interaction of Src and NR2B with Tau in THY-Tau22 animals. These are the first data demonstrating a relationship between Tau pathology and synaptic effects of BDNF and supporting a contribution of defective BDNF response and impaired NMDAR function to the cognitive deficits associated with Tauopathies. CI - (c) 2012 The Authors Aging Cell (c) 2012 Blackwell Publishing Ltd/Anatomical Society of Great Britain and Ireland. FAU - Burnouf, Sylvie AU - Burnouf S AD - Universite Lille-Nord de France, UDSL, F-59045, Lille Cedex, France. FAU - Martire, Alberto AU - Martire A FAU - Derisbourg, Maxime AU - Derisbourg M FAU - Laurent, Cyril AU - Laurent C FAU - Belarbi, Karim AU - Belarbi K FAU - Leboucher, Antoine AU - Leboucher A FAU - Fernandez-Gomez, Francisco J AU - Fernandez-Gomez FJ FAU - Troquier, Laetitia AU - Troquier L FAU - Eddarkaoui, Sabiha AU - Eddarkaoui S FAU - Grosjean, Marie-Eve AU - Grosjean ME FAU - Demeyer, Dominique AU - Demeyer D FAU - Muhr-Tailleux, Anne AU - Muhr-Tailleux A FAU - Buisson, Alain AU - Buisson A FAU - Sergeant, Nicolas AU - Sergeant N FAU - Hamdane, Malika AU - Hamdane M FAU - Humez, Sandrine AU - Humez S FAU - Popoli, Patrizia AU - Popoli P FAU - Buee, Luc AU - Buee L FAU - Blum, David AU - Blum D LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20121123 PL - England TA - Aging Cell JT - Aging cell JID - 101130839 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 0 (tau Proteins) SB - IM MH - Alzheimer Disease/genetics/*metabolism MH - Animals MH - Brain-Derived Neurotrophic Factor/*metabolism/pharmacology MH - Disease Models, Animal MH - Hippocampus/drug effects/metabolism/*physiology MH - Humans MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Mice, Transgenic MH - Receptors, N-Methyl-D-Aspartate/*metabolism MH - Synaptic Transmission/drug effects/*physiology MH - Transgenes MH - tau Proteins/biosynthesis/*genetics EDAT- 2012/10/23 06:00 MHDA- 2013/10/01 06:00 CRDT- 2012/10/23 06:00 PHST- 2012/09/20 00:00 [accepted] PHST- 2012/10/23 06:00 [entrez] PHST- 2012/10/23 06:00 [pubmed] PHST- 2013/10/01 06:00 [medline] AID - 10.1111/acel.12018 [doi] PST - ppublish SO - Aging Cell. 2013 Feb;12(1):11-23. doi: 10.1111/acel.12018. Epub 2012 Nov 23.